Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

Delayed Data
As of Oct 02
 +0.19 / +6.23%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +224.07% increase from the last price of 3.24.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 39.52%
Growthannually -90.86%


Growthquarterly 3.12%
Growthannually 50.68%
Key to the earnings and sales forecast charts.